Meyka Pro banner
Abbisko Cayman Limited

Abbisko Cayman Limited Fundamental Analysis

2256.HKHKSE
HealthcareBiotechnology
HK$10.68
HK$0.00(0.00%)
Hong Kong Market is Open · 15:51

Abbisko Cayman Limited Fundamental Analysis

Abbisko Cayman Limited (2256.HK) shows weak financial fundamentals with a PE ratio of 113.73, profit margin of 9.03%, and ROE of 2.67%. The company generates $0.7B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position31.88%
Current Ratio4.98

Areas of Concern

ROE2.67%
Operating Margin4.56%
We analyze 2256.HK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 47.5/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
47.5/100

We analyze 2256.HK's fundamental strength across five key dimensions:

Efficiency Score

Weak

2256.HK struggles to generate sufficient returns from assets.

ROA > 10%
2.35%

Valuation Score

Moderate

2256.HK shows balanced valuation metrics.

PE < 25
113.73
PEG Ratio < 2
1.32

Growth Score

Weak

2256.HK faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

2256.HK maintains a strong and stable balance sheet.

Debt/Equity < 1
0.16
Current Ratio > 1
4.98

Profitability Score

Moderate

2256.HK maintains healthy but balanced margins.

ROE > 15%
266.54%
Net Margin ≥ 15%
9.03%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is 2256.HK Expensive or Cheap?

P/E Ratio

2256.HK trades at 113.73 times earnings. This suggests a premium valuation.

113.73

PEG Ratio

When adjusting for growth, 2256.HK's PEG of 1.32 indicates fair valuation.

1.32

Price to Book

The market values Abbisko Cayman Limited at 2.96 times its book value. This may indicate undervaluation.

2.96

EV/EBITDA

Enterprise value stands at 181.58 times EBITDA. This signals the market has high growth expectations.

181.58

How Well Does 2256.HK Make Money?

Net Profit Margin

For every $100 in sales, Abbisko Cayman Limited keeps $9.03 as profit after all expenses.

9.03%

Operating Margin

Core operations generate 4.56 in profit for every $100 in revenue, before interest and taxes.

4.56%

ROE

Management delivers $2.67 in profit for every $100 of shareholder equity.

2.67%

ROA

Abbisko Cayman Limited generates $2.35 in profit for every $100 in assets, demonstrating efficient asset deployment.

2.35%

Following the Money - Real Cash Generation

Operating Cash Flow

Abbisko Cayman Limited produces operating cash flow of $91.10M, showing steady but balanced cash generation.

$91.10M

Free Cash Flow

Abbisko Cayman Limited generates strong free cash flow of $87.23M, providing ample flexibility for dividends, buybacks, or growth.

$87.23M

FCF Per Share

Each share generates $0.12 in free cash annually.

$0.12

FCF Yield

2256.HK converts 1.16% of its market value into free cash.

1.16%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

113.73

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

1.32

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.96

vs 25 benchmark

P/S Ratio

Price to sales ratio

10.67

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.16

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.98

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.03

vs 25 benchmark

ROA

Return on assets percentage

0.02

vs 25 benchmark

ROCE

Return on capital employed

0.01

vs 25 benchmark

How 2256.HK Stacks Against Its Sector Peers

Metric2256.HK ValueSector AveragePerformance
P/E Ratio113.7329.15 Worse (Expensive)
ROE2.67%438.00% Weak
Net Margin9.03%-11409.00% (disorted) Weak
Debt/Equity0.160.78 Strong (Low Leverage)
Current Ratio4.985.14 Strong Liquidity
ROA2.35%-21.00% (disorted) Weak

2256.HK outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Abbisko Cayman Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ